Full Text View
Tabular View
Study Results
Related Studies
Safety and Efficacy of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis
This study has been completed.
Study NCT00287729   Information provided by InterMune

First Received on February 6, 2006.   Last Updated on May 12, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Idiopathic Pulmonary Fibrosis
Additional conditions recognized in this trial
Fibrosis
Pulmonary Fibrosis
More general conditions related to this trial
Idiopathic Interstitial Pneumonias
Lung Diseases
Lung Diseases, Interstitial
Pathologic Processes
Respiratory Tract Diseases
Interventions listed in this trial
Pirfenidone
Placebo
More general drug interventions related to this trial
Analgesics
Analgesics, Non-Narcotic
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Antineoplastic Agents
Antirheumatic Agents
Central Nervous System Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
InterMune


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services